Umi Chong

Umi Chong has worked in the finance and accounting industry since 2000. Umi began their career at Syrrx, Inc. as the Controller, where they worked until 2005. Umi then joined Takeda San Diego as the Sr. Director of Finance & Site Controller, where they worked until 2022. Umi is currently employed at 858 Therapeutics as the Sr. Director of Finance and Controller.

Umi Chong attended Indiana University Bloomington.